Dr Cedric Coulouarn has a long-standing expertise and track record in liver cancer with focus on TGF-beta signaling, non-coding RNA and functional genomics, including a 5-year experience at the National Cancer Institute (NIH, Bethesda, USA). He currently heads a team at Inserm in France focused on studying the role of TGF-beta signalling in liver carcinogenesis. He is an active member of the French and European associations for the Study of the Liver (AFEF and EASL), International Liver Cancer Association (ILCA), European Network for the Study of Cholangiocarcinoma (ENS-CCA). Dr Coulouarn is also acting as a referee in scientific committees for evaluation of French and international Grants. He is teaching at University Paris-Diderot and University of Rennes 1 (France).